MARKSANS PHARMA
Back to Income Statement
|
MARKSANS PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,623 Cr | ₹2,177 Cr | ₹1,852 Cr | ₹1,491 Cr | ₹1,376 Cr |
What is the latest Revenue of MARKSANS PHARMA ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹2,623 Cr |
| Mar2025 | ₹2,177 Cr |
| Mar2024 | ₹1,852 Cr |
| Mar2023 | ₹1,491 Cr |
| Mar2022 | ₹1,376 Cr |
How is Revenue of MARKSANS PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,623 Cr | 20.46 | |
| Mar2025 | ₹2,177 Cr | 17.56 | |
| Mar2024 | ₹1,852 Cr | 24.23 | |
| Mar2023 | ₹1,491 Cr | 8.33 | |
| Mar2022 | ₹1,376 Cr | - | |
Compare Revenue of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹12,639.7 Cr | 1.1% | -0.3% | 21.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,471.0 Cr | -0.4% | 0.9% | 19.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,631.0 Cr | -1.2% | 21.1% | 29.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,157.0 Cr | -2.3% | 0.3% | 34.8% | Stock Analytics | |
| CIPLA | ₹118,108.0 Cr | 0.7% | 1.5% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,578.0 Cr | -0.3% | -7.1% | -3.9% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 1.1% |
-0.3% |
21.9% |
| SENSEX | -0.4% |
0.8% |
-3% |
You may also like the below Video Courses